Ben Mazer, MD, anatomic and clinical pathologist at Yale New Haven Hospital, joins Chadi to recap the rise and fall of the now infamous Theranos – a private lifestyle and healthcare startup company that claimed to have innovative, revolutionary blood-testing technology that was ultimately proven ineffective. Dr. Mazer explains how Elizabeth Holmes, the founder of the company, allegedly engaged in a multi-million dollar scheme to defraud investors, doctors, and patients. Fast forward to the present day and the Theranos trial is well underway. This episode provides all of the background information and context as the trial continues to unfold. You won’t want to miss it.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
